This study, conducted in a population of women with a recent diagnosis of early breast cancer in Spain, showed higher BMI in luminal A and HER2-positive postmenopausal patients, and higher BMI in patients with low MBD regardless of menopausal status. The gene discussed is ERBB2; the disease is breast carcinoma.